HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (OTCBB:ARDM) (the “Company”) today announced financial results for the third quarter and nine months ended September 30, 2011.
Total revenue was approximately $0.2 million for the third quarter of 2011, compared with approximately $0.2 million for the third quarter of 2010. Revenue for both periods reflects the quarterly royalty payment from Zogenix, Inc. for product sales of SUMAVEL® DosePro™ needle-free delivery system for the treatment of acute migraine and cluster headaches.
